Literature DB >> 15319168

Relation between the tumor necrosis factor-alpha (TNF-alpha) gene and protein expression, and clinical, biochemical, and genetic markers: age, body mass index and uric acid are independent predictors for an elevated TNF-alpha plasma level in a complex risk model.

Susanne Schulz1, Undraga Schagdarsurengin, Thomas Suss, Ursula Müller-Werdan, Karl Werdan, Christiane Gläser.   

Abstract

BACKGROUND: Tumor necrosis factor-alpha (TNF-alpha) has been implicated in the pathogenesis of numerous complex diseases. The plasma level of this pro-inflammatory cytokine is associated with a variety of different risk factors, but little is known about the genetic background and the complex interactions.
METHODS: in this clinical study, correlations were studied between plasma levels of circulating TNF-alpha protein (ELISA), its mRNA expression in monocytes (RT-PCR) and genetic variants of TNF-alpha gene (SSCP), with several diseases, including obesity, atherosclerosis, diabetes mellitus, hypertension, as well as risk factors such as age, gender, inflammatory markers, the coagulation\fibrinolysis balance, and lipid metabolism. One hundred and ninety four clinically and biochemically well-characterized patients were enrolled.
RESULTS: At the transcriptional level, measured in monocytes, no association with any clinical or biochemical parameter investigated was found, including TNF-alpha protein level. Investigating the influence of genetic variants of the TNF-alpha gene on mRNA and protein levels, only one promoter polymorphism, namely c.-238G > A, was shown to be associated with transcriptional but not with translational expression. However, at the translational level, significant positive, but weak associations were determined for obesity (P -/+ 0.037), age (P -/+ 0.038), uric acid (P < 0.001), body mass index (P -/+ 0.01), plasminogen (P -/+ 0.013), and fibrinogen (P -/+ 0.002) in bivariate regression analyses, whereas HDL-cholesterol (P -/+ 0.005) was shown to be negatively correlated. However, investigating confounding effects in stepwise multivariate regression analysis, body mass index (P -/+ 0.009), uric acid (P -/+ 0.026) and age (P -/+ 0.037) turned out to be significantly associated with plasma levels of circulating TNF-alpha (adjusted R(2) -/+ 0.117; SE: 0.688).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319168

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  7 in total

1.  Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging.

Authors:  Anna Csiszar; Nazar Labinskyy; Kira Smith; Aracelie Rivera; Zsuzsanna Orosz; Zoltan Ungvari
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Tumor necrosis factor alpha -238 G/A and -308 G/A polymorphisms and soluble TNF-α levels in chronic kidney disease: correlation with clinical variables.

Authors:  Diana I Vázquez-Huerta; Bertha A Alvarez-Rodríguez; Jorge F Topete-Reyes; José F Muñoz-Valle; Renato Parra-Michel; Francisco Fuentes-Ramírez; María A Salazar-López; Yeminia Valle; Zyanya Reyes-Castillo; A Cruz-González; Lorena M Brennan-Bourdon; Norma Torres-Carrillo
Journal:  Int J Clin Exp Med       Date:  2014-08-15

Review 3.  Inflammation and endothelial dysfunction during aging: role of NF-kappaB.

Authors:  Anna Csiszar; Mingyi Wang; Edward G Lakatta; Zoltan Ungvari
Journal:  J Appl Physiol (1985)       Date:  2008-07-03

4.  Effects of aging, TNF-α, and exercise training on angiotensin II-induced vasoconstriction of rat skeletal muscle arterioles.

Authors:  Yoonjung Park; Rhonda D Prisby; Brad J Behnke; James M Dominguez; Lisa A Lesniewski; Anthony J Donato; Judy Muller-Delp; Michael D Delp
Journal:  J Appl Physiol (1985)       Date:  2012-08-23

Review 5.  Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation.

Authors:  Henry S Cheng; Makon-Sébastien Njock; Nadiya Khyzha; Lan T Dang; Jason E Fish
Journal:  Front Genet       Date:  2014-12-10       Impact factor: 4.599

6.  The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.

Authors:  A R J V Vossen; C B Ardon; H H van der Zee; E Lubberts; E P Prens
Journal:  Br J Dermatol       Date:  2019-04-12       Impact factor: 9.302

7.  Gene polymorphisms in association with emerging cardiovascular risk markers in adult women.

Authors:  Amy Z Fan; Ajay Yesupriya; Man-huei Chang; Meaghan House; Jing Fang; Renée Ned; Donald Hayes; Nicole F Dowling; Ali H Mokdad
Journal:  BMC Med Genet       Date:  2010-01-15       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.